KCTD13 antibody (N-Term)
Quick Overview for KCTD13 antibody (N-Term) (ABIN633662)
Target
See all KCTD13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- KCTD13 antibody was raised against the N terminal of KCTD13
-
Purification
- Affinity purified
-
Immunogen
- KCTD13 antibody was raised using the N terminal of KCTD13 corresponding to a region with amino acids PGPAAYGLKPLTPNSKYVKLNVGGSLHYTTLRTLTGQDTMLKAMFSGRVE
-
-
-
-
Application Notes
-
WB: 0.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
KCTD13 Blocking Peptide, (ABIN5614303), is also available for use as a blocking control in assays to test for specificity of this KCTD13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KCTD13 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KCTD13 (Potassium Channel Tetramerisation Domain Containing 13 (KCTD13))
-
Alternative Name
- KCTD13
-
Background
- KCTD13 mRNA is expressed in 3T3-L1 adipocytes and THP-1 macrophages. It is suggested that this gene provides a link between cytokine activation and DNA replication in liver as well as in other tissues.
-
Molecular Weight
- 36 kDa (MW of target protein)
Target
-